TABLE 1.
Participant characteristics
| Demographic characteristics of full analysis set | |||
|---|---|---|---|
| Liraglutide (n = 30) | Placebo (n = 26) | Total (n = 56) | |
| Age, years, mean (SD) | 43.0 (10.88) | 48.1 (12.63) | 45.4 (11.89) |
| Female, n (%) | 22 (73.3) | 16 (61.5) | 38 (67.9) |
| Race, n (%) | |||
| White | 21 (70.0) | 19 (73.1) | 40 (71.4) |
| Black | 9 (30.0) | 6 (23.1) | 15 (26.8) |
| Asian | 0 (0.0) | 1 (3.8) | 1 (1.8) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 8 (26.7) | 9 (34.6) | 17 (30.4) |
| Not Hispanic or Latino | 22 (73.3) | 17 (65.4) | 39 (69.6) |
| Height, cm, mean (SD) | 165.67 (9.16) | 166.57 (9.04) | 166.09 (9.04) |
| Weight, kg, mean (SD) | 93.55 (12.81) | 96.30 (13.04) | 94.82 (12.87) |
| BMI, kg/m2, mean (SD) | 34.18 (2.62) | 34.77 (2.92) | 34.45 (2.76) |
BMI, body mass index; SD, standard deviation.